Abstract:
Scientists at Northwestern University have developed an ultra-sensitive technology based on gold nanoparticles and DNA that can detect prostate specific antigen (PSA) when present at extremely low levels in a blood sample. This promising new protein-detection method could be used to monitor prostate cancer patients following surgery and to detect the early signs of breast cancer.